BMT Clinical Account Manager - TX
-
Healthcare
Job Description & How to Apply Below
Blood & Marrow Transplant Clinical Account Manager
Texas
Omeros is currently recruiting a Blood & Marrow Transplant Clinical Account Manager for the Texas Region to join our Launch Team of dynamic sales professionals. Reporting to the Regional Business Director, Blood & Marrow Transplant, East, you will primarily call upon Hematopoietic Stem Cell Transplant (HSCT) Centers and their affiliated health care professionals in this assigned geographic territory.
Omeros is an innovative biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for both large-market and orphan indications, with a focus on complement-mediated diseases, cancers, and addictive or compulsive disorders. Omeros’ lead complement inhibitor YARTEMLEA® (narsoplimab-wuug), which targets the lectin pathway’s effector enzyme MASP-2, is FDA-approved and commercially available in the U.S. for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) in adult and pediatric patients aged two years and older.
A marketing authorization application seeking approval of YARTEMLEA for TA-TMA is currently under review at the European Medicines Agency. OMS
1029, Omeros’ long-acting MASP-2 inhibitor, has successfully completed Phase 1 clinical trials.
Under a recently announced asset purchase and licensing agreement, Novo Nordisk acquired global rights to zaltenibart (formerly OMS
906), an inhibitor of MASP-3, the alternative pathway’s key activator, which is in clinical development for PNH and other alternative pathway indications, along with associated intellectual property and related assets. Omeros’ pipeline also includes OMS
527, a phosphodiesterase 7 inhibitor in clinical development for cocaine use disorder, which is fully funded by the National Institute on Drug Abuse, and a growing portfolio of novel recombinant antibodies targeting multidrug-resistant organisms and novel molecular and cellular therapeutic programs for oncology. For more information about Omeros and its programs, visit
- Responsible for managing the business within a specific geographical territory area
- Responsible for disease state awareness materials and educating customers on the signs and symptoms of thrombotic microangiopathy (TMA) as it relates to HSCT patients in their targeted institutions
- Participate in and help create pre-launch strategies that will be used to ensure a successful launch of a product currently under review by the FDA for the treatment of HSCT-TMA
- Pending FDA approval, this individual will be responsible for educating customers on a monoclonal antibody used to treat HSCT-TMA in targeted hospitals that are located across the assigned territory with a focus on the following departments: HSCT physicians, hematologists, nephrologists, nurses, and pharmacists
- Some responsibilities as they relate to the reimbursement and access of the product and will call on Pharmacy directors, social workers and others related to ensuring the access and distribution of the product
- Execute on the National sales and marketing strategy and create a territory business plan to maximize opportunity
- Work in partnership with home office personnel, the Brand team and the National and Corporate account teams for pull-through of product sales
- Responsible for running the business by analyzing account and physician sales data and creating territory tactical plans and providing solutions to grow the business
- Experience in and knowledge of Microsoft applications as well as Veeva CRM in order to track call activity and sales progress
- Maintain Company and Industry Compliance Rules
- Bachelor’s degree is required, with a…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).
View / Apply for Jobs
Matching My Jurisdiction